Position in AXSM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$125,876,888
+$35,386,805 QoQ
Shares Held
514,266
+3.8% QoQ
Ownership
0.982%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 500 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. AXSM ranks #17 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in AXSM
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,876,888 | 514,266 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $90,490,083 | 495,456 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $48,888,864 | 468,329 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $51,025,275 | 437,497 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $34,100,029 | 403,026 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $35,167,568 | 391,316 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $32,539,468 | 404,217 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $30,766,969 | 385,551 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $15,529,839 | 195,123 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $14,692,415 | 210,222 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $15,106,552 | 210,222 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $12,966,492 | 210,222 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $19,775,900 | 256,397 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,440,434 | 256,397 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $8,925,661 | 233,046 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $7,337,619 | 177,280 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $7,266,189 | 192,329 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $6,339,163 | 192,329 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $4,197,563 | 62,223 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $11,772,543 | 207,922 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $22,396,836 | 274,909 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $20,224,668 | 283,855 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $33,421,971 | 406,198 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $18,142,701 | 308,392 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||